Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease

You-Sun KIM; Edward-H. HURLEY; Yoojeong PARK; Sungjin KO.
Intestinal Research ; : 420-432, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1000600

Documentos relacionados

  1. Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease.
  2. Biomedical research in france and brazil: an analysis of significant differences and ethical issues
  3. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
  4. The Role of Nutrition in Cancer Patients.
  5. Platinossomose em felino doméstico no município de Pelotas, RS, Brasil
  6. [Current Status and Perspective of Medical Setting for Pediatric Cancers in Japan].
  7. Prognostic and predictive role of the tumor immune landscape.
  8. Primary sclerosing cholangitis: a clinical update.
  9. Autophagy and autophagy-related pathways in cancer.
  10. Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial.